EmailFacebookXLinkedIn

laurence.jocaille_120

About laurence.jocaille_120

This author has not yet filled in any details.
So far laurence.jocaille_120 has created 393 blog entries.

Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)

2021-07-29T22:38:05+02:00

Lamont EB, Schilsky RL, He Y, Muss H, Cohen HJ, Hurria A, Meilleur A, Kindler HL, Venook A, Lilenbaum R, Niell H, Goldberg RM, Joffe S; Alliance for Clinical Trials in Oncology.   J Natl Cancer Inst. 2014 Nov 27;107(1):336. doi: 10.1093/jnci/dju336. Print 2015 Jan. (Pubmed)

Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)2021-07-29T22:38:05+02:00

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?

2021-07-29T22:38:06+02:00

Shumway DA, Hamstra DA.  J Clin Oncol. 2015 Mar 1;33(7):676-8. doi: 10.1200/JCO.2014.59.4093. Epub 2015 Jan 5. (Journal of Clinical Oncology)

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?2021-07-29T22:38:06+02:00

Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.

2021-07-29T22:38:06+02:00

Ostronoff F, Othus M, Lazenby M, Estey E, Appelbaum FR, Evans A, Godwin J, Gilkes A, Kopecky KJ, Burnett A, List AF, Fang M, Oehler VG, Petersdorf SH, Pogosova-Agadjanyan EL, Radich JP, Willman CL, Meshinchi S, Stirewalt DL.  J Clin Oncol. 2015 Apr 1;33(10):1157-64. doi: 10.1200/JCO.2014.58.0571. Epub 2015 Feb 23. (Pubmed)

Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.2021-07-29T22:38:06+02:00

Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.

2021-07-29T22:38:06+02:00

Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A.   J Clin Oncol. 2015 May 1;33(13):1453-9. doi: 10.1200/JCO.2014.58.7550. Epub 2015 Mar 23. (Pubmed)

Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.2021-07-29T22:38:06+02:00

Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort study.

2021-07-29T22:38:06+02:00

Huisman MG, Audisio RA, Ugolini G, Montroni I, Vigano A, Spiliotis J, Stabilini C, de Liguori Carino N, Farinella E, Stanojevic G, Veering BT, Reed MW, Somasundar PS, de Bock GH, van Leeuwen BL.  Eur J Surg Oncol. 2015 Apr 13. pii: S0748-7983(15)00375-3. doi: 10.1016/j.ejso.2015.02.018. [Epub ahead of print] (Pubmed)

Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort study.2021-07-29T22:38:06+02:00

Stay in touch and share our news!

SIOG Head Office

  • International Society of Geriatric Oncology
    P/A Comptabilis
    9 route des Jeunes
    1227 Les Acacias - Switzerland

  • +41 22 734 73 43
  • enquiry@siog.org

ECOSOC Special

In Special Consultative Status with the United Nations Economic and Social Council (ECOSOC).

Quick links

 

Subscribe to our newsletter

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Go to Top